Vijayakrishna K Gadi

7PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
Hybrid Computer Vision Model to Predict Lung Cancer in Diverse Populations.

Abdul J Zakkar, Nazia Perwaiz, Vikram Harikrishnan

|Jun 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa

|Sep 15, 2022
Effect of Ado-Trastuzumab Emtansine on Autologous Platelet Kinetics and Function.

Ali M Ansary, Moritz Stolla, Jill Corson

|Jun 02, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Sara M Tolaney, Nabihah Tayob, Chau Dang

Pageof 2